Universal Vision Biotechnology Co., Ltd. (TPEX:3218)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
133.50
-0.50 (-0.37%)
Jun 18, 2026, 1:30 PM CST
Market Cap11.31B -35.8%
Revenue (ttm)4.17B -2.6%
Net Income960.76M -14.5%
EPS11.20 -15.3%
Shares Out 84.72M
PE Ratio11.92
Forward PE9.77
Dividend7.75 (5.81%)
Ex-Dividend DateMar 26, 2026
Volume126,982
Open133.50
Previous Close134.00
Day's Range133.00 - 135.00
52-Week Range122.00 - 219.50
Beta0.32
AnalystsHold
Price Target150.00 (+12.36%)
Earnings DateAug 11, 2026

About TPEX:3218

Universal Vision Biotechnology Co., Ltd., a biotech company, provides vision care services in Taiwan and China. The company offers various glasses and lenses for vision correction, contact lens solutions, and related eye care products; equipment rental and technical services for laser vision correction instruments; and technology and services for cataract and dry eye examination and treatment instruments. It also trades in medical and pharmaceutical consumables, including ophthalmic drugs, medical supplies, and consumables; and provides adminis... [Read more]

Sector Healthcare
Founded 1992
Employees 401
Stock Exchange Taipei Exchange
Ticker Symbol 3218
Full Company Profile

Financial Performance

In 2025, TPEX:3218's revenue was 4.20 billion, a decrease of -0.57% compared to the previous year's 4.23 billion. Earnings were 1.04 billion, a decrease of -2.07%.

Financial Statements